Review elucidates Vascular Endothelial Growth Factor's (VEGF) dual role in intracerebral hemorrhage pathology, pinpointing therapeutic targets.
Background
Intracerebral hemorrhage (ICH), caused by ruptured cerebral blood vessels, leads to significant brain damage. Current treatments often fall short in addressing the complex secondary injury mechanisms, including impaired hemostasis and blood-brain barrier dysfunction. Vascular endothelial growth factor (VEGF), a key mediator of angiogenesis, is highly expressed in cerebrovascular diseases and has shown promise in animal models due to its neuroprotective effects and ability to promote blood vessel growth. This review aims to consolidate understanding of VEGF's multifaceted involvement in ICH.
Study Design
This comprehensive review systematically examined existing literature on intracerebral hemorrhage (ICH), focusing on the multifaceted involvement of Vascular Endothelial Growth Factor (VEGF). The authors synthesized findings from numerous preclinical studies and animal therapeutic experiments, analyzing VEGF's roles in angiogenesis, hemostasis, blood-brain barrier function, inflammation, apoptosis, neurotrophy, and protein clearance. The study's design aimed to consolidate current knowledge regarding VEGF's dual pathological contributions and identify promising therapeutic targets within its pathways for ICH.
Results
The review comprehensively elucidated Vascular Endothelial Growth Factor (VEGF)'s complex dual role in intracerebral hemorrhage (ICH) pathology. It highlighted that VEGF acts as a crucial mediator of angiogenesis, promoting new blood vessel growth to enhance oxygen and nutrient supply to ischemic brain regions post-ICH. Furthermore, VEGF was found to exert significant neuroprotective effects by modulating key pathological processes including inflammation, apoptosis, neurotrophy, and protein clearance, contributing to tissue repair and functional recovery.
However, the review also identified that dysregulated VEGF activity can contribute to detrimental effects, particularly in the acute phase of ICH, by exacerbating blood-brain barrier disruption and promoting cerebral edema, which can worsen secondary brain injury. The synthesis of animal therapeutic experiments revealed promising results for targeting VEGF pathways, suggesting that precise modulation of VEGF activity could offer a window for therapeutic intervention, balancing its beneficial angiogenic and neuroprotective roles against its potential to worsen acute injury.
Key Findings
- VEGF plays a dual role in ICH pathology, acting as both a neuroprotective/angiogenic factor and a potential contributor to acute injury.
- VEGF promotes angiogenesis, increasing oxygen and nutrient supply to damaged brain tissues following ICH.
- VEGF exerts neuroprotective effects by modulating inflammation, apoptosis, neurotrophy, and protein clearance.
- Dysregulated VEGF activity can exacerbate blood-brain barrier disruption and cerebral edema in the acute phase of ICH.
- Targeting VEGF pathways shows promise in animal therapeutic experiments for ICH treatment.
Why It Matters
This review significantly advances our understanding of intracerebral hemorrhage (ICH) pathology by clarifying Vascular Endothelial Growth Factor (VEGF)'s complex, dual role. For clinicians and researchers, this means moving beyond a simplistic view of VEGF as solely beneficial or detrimental, opening avenues for more nuanced therapeutic strategies. Precisely modulating VEGF activity could offer novel interventions for ICH patients, potentially improving outcomes by leveraging its neuroprotective and angiogenic properties while mitigating acute phase adverse effects like edema. This could lead to the development of new compounds or optimized protocols that target specific VEGF isoforms or signaling pathways, perhaps through timed administration or localized delivery, to maximize therapeutic benefit. While clinical translation requires extensive further research, this work provides a critical mechanistic framework for developing advanced treatments for cerebrovascular diseases.
intracerebral hemorrhage
ich
vegf
angiogenesis
neuroprotection
blood-brain-barrier